What ’ s new ?
Page 2 Newsletter 4 / 2013
EUROGIA + ( EUREKA Cluster )
EUROGIA + is a EUREKA Cluster for Low-Carbon Energy Technologies . It facilitates the deployment of existing technologies and supports the development of highly innovative new technical solutions by encouraging cooperation and coordination among European companies . The EUREKA ‘ Label ’ is awarded to project proposals with the potential of developing breakthrough innovations . It allows successful consortia to apply for national funding ( funding is based on the OCS of the MOITAL rules ). * Notice : large enterprises must be members of the cluster . All other entities will pay the cluster 1.1 % of the overall grant ( if won ). The 2013 open call for proposals is continuously open for submission all year round , with 4 cut-off dates . Next cut-off is 24 / 5 / 2013 . EUROGIA + website : http :// www . eurogia . com / Call for proposals and rules of participation : http :// www . eurogia . com / submitting / criteria . html
What ’ s new ?
� Experts for Horizon 2020 Advisory Groups : Call for expressions of interest
The European Commission is widening its search for experts from all fields to participate in shaping the agenda of Horizon 2020 , the European Union ' s future funding program for research and innovation . The experts of the advisory groups will provide high quality and timely advice for the preparation of the Horizon 2020 calls for project proposals . To reach the broadest range of profiles suited to contribute to the European Union ' s vision and objectives for Horizon 2020 , the Commission is calling for expressions of interest with the aim of creating lists of high level experts that will participate in each of these groups . Each advisory group shall be representative of the broad constituency of stakeholders , including industry and research actors as well as representatives of civil society . The call for expressions of interest is open for the lifetime of the Horizon 2020 program . Experts can register at any time ; expressions of interest will be taken into account for the renewal of groups at the end of each mandate . Further information about expertise and profiles sought , as well as instructions for registration can be found here : http :// ec . europa . eu / research / horizon2020 / index _ en . cfm ? pg = h2020-experts
�
Innovation Medicine Initiative ( IMI ) consultation toward H2020 The Innovative Medicines Initiative ( IMI ) set up under FP7 has demonstrated the value of public private partnerships in advancing biomedical research . IMI provides an ideal framework for large scale open collaborations between industry and public partners , and delivers results directly applicable in pharmaceutical R & D , as well as in regulatory and clinical practice with high efficiency . Based on the success of IMI , it was envisage renewing this experience under H2020 . After preliminary internal and on line consultations with some stakeholder groups , a general framework was built around 7 axis of activity ( from reclassification of diseases , through safety and efficacy , to product development ). However your input on the current proposal , in order to help define the key areas which will eventually be included in the final version of the program will be
appreciated . Here you will find the results of the consultations an address for your comments : http :// www . efpia . eu / public-consultations / sra-public-consultation